Drug information for ZYFLO CR
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET, EXTENDED RELEASE; ORAL
600MG
Prescription
(Reference Drug)
ZILEUTON
zileuton
CORNERSTONE THERAP
22052
2011-12-02 Label
2011-12-01 Letter
2009-11-12 Letter
2009-08-28 Label
2008-10-03 Review
2007-06-04 Label
2007-06-04 Letter
Drug Adverse Effects information for ZYFLO CR
Role code
Indications
Reaction
# Reports
PS
ASTHMA
ARTHRALGIA
1
PS
ASTHMA
DECREASED ACTIVITY
1
PS
ASTHMA
EXERCISE TOLERANCE DECREASED
1
PS
ASTHMA
MOOD ALTERED
1
PS
ASTHMA
PRODUCT FORMULATION ISSUE
1
PS
ASTHMA
TREATMENT FAILURE
1
PS
BRONCHIAL HYPERREACTIVITY
ARTHRALGIA
1
PS
BRONCHIAL HYPERREACTIVITY
DECREASED ACTIVITY
1
PS
BRONCHIAL HYPERREACTIVITY
EXERCISE TOLERANCE DECREASED
1
PS
BRONCHIAL HYPERREACTIVITY
MOOD ALTERED
1
PS
BRONCHIAL HYPERREACTIVITY
PRODUCT FORMULATION ISSUE
1
PS
BRONCHIAL HYPERREACTIVITY
TREATMENT FAILURE
1
PS
OSTEOPENIA
ANGIOEDEMA
1
PS
OSTEOPENIA
HYPERHIDROSIS
1
PS
OSTEOPENIA
HYPERSENSITIVITY
1
PS
OSTEOPENIA
MIDDLE EAR EFFUSION
1
PS
OSTEOPENIA
NAUSEA
1
PS
OSTEOPENIA
RHINORRHOEA
1
PS
OSTEOPENIA
SINUS HEADACHE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
ANGIOEDEMA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HYPERHIDROSIS
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HYPERSENSITIVITY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
MIDDLE EAR EFFUSION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
NAUSEA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
RHINORRHOEA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
SINUS HEADACHE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ARTHRITIS
1
Ads by Google